Herve Ginisty, CSO and Severine Hountondji, Business Development Manager will be pleased to discuss your projects.
To make an appointment, please contact us at hountondji@gtptech.com or call +33 5 61287020
Visit www.oxfordglobal.co.uk
February 2012
Herve Ginisty, CSO and Severine Hountondji, Business Development Manager will be pleased to discuss your projects.
To make an appointment, please contact us at hountondji@gtptech.com or call +33 5 61287020
Visit www.oxfordglobal.co.uk
November 2011
From Nov 15, 2011 until Feb 15, 2012
Whether you are a scientist with a particular interest in innovative expression systems or looking for a competitive system to express your protein of interest, we hope you will be interested in our “experimental” approach.
Read moreAugust 2011
Do not hesitate to contat us at contact@gtptech.com or + 33 561 28 70 20 to schedule a meeting.
June 2011
In this recombinant project using supposedly identical insect cell lines, analysis revealed subtle differences in N-glycosylation profiles suspected to be at the origin of variations in later protein-protein interactions.
Read moreMarch 2011
Dr. Herve Ginisty & Christopher Pease will be happy to discuss your recombinant challenges and potential contribution to your success.
To make an appointment, please contact us at pease@gtptech.com or +33 5 61287020.
November 2010
When the antibody and the 'body' come together
Antibodies are only as good as the antigens used to generated them. Put chances on your side by calling on combined expertise to develop the Ab-Ag package.
If you'd rather focus on your research than on constructing projects that combine constraints from the immunisation process with those from the protein engineering, you can hand us the challenge.
Indicia and GTP Technology each have over 10 years experience in this field and joined competencies to help you obtain the Ab-rAg you want.
September 2010
Herve Ginisty, CSO and Severine Hountondji, Business Development Manager will be pleased to discuss your projects.
To make an appointment, please contact us at hountondji@gtptech.com or call +33 5 61287020
August 2010
The company has introduced enhancements to induced expression and developed a constitutive promoter for continuous fermentation processes in L. lactis. In doing so it has overcome most of the difficulty of balancing translation/secretion in L. lactis.
The system is finally better suited for production, in particular for therapeutic or vaccine-related proteins.
For more information,
Improvements in continuous fermentation processes with L. lactis
June 2010
Do not hesitate to contact us to schedule a meeting.
April 2010
With over 800 projects performed over the past 10 years, GTP Technology has developed a considerable know how in the production of proteins from various types and origins. To capitalize on this know-how, we have developed a catalogue of recombinant proteins for research.
Read more